Almirall

Almirall

ALM.MCApproved
Barcelona, SpainFounded 1943almirall.com

A global pharmaceutical company focused on medical dermatology and skin health.

Market Cap
$2.8B
Founded
1943
Focus
Small Molecules

ALM.MC · Stock Price

USD 11.420.73 (-6.01%)

Historical price data

About

A global pharmaceutical company focused on medical dermatology and skin health.

Pipeline Snapshot

66

66 drugs in pipeline, 21 in Phase 3

DrugIndicationStage
lebrikizumabAtopic DermatitisApproved
Tildrakizumab 100 mg Solution for InjectionPlaque PsoriasisApproved
Pidotimod + PlaceboRecurrent Respiratory Tract InfectionsApproved
Tiotropium + AclidiniumPulmonary Disease, Chronic ObstructiveApproved
dapsone gelAcne VulgarisApproved

Funding History

1
IPOUndisclosedUndisclosedJul 3, 2007

FDA Approved Drugs

9
KLISYRINDADec 14, 2020
SEYSARANDAOct 1, 2018
ACZONENDAFeb 24, 2016
Publications
20
Patents
5
Pipeline
66
FDA Approvals
9

Company Info

TypePublic
Founded1943
LocationBarcelona, Spain
StageApproved
SIMILAR COMPANIES
A4Cell
A4Cell
Pre-clinical · Barcelona
Ability Pharma
Ability Pharma
Phase 2 · Barcelona
Abyntek Biopharma
Abyntek Biopharma
Pre-clinical · Derio
Acellera
Acellera
Pre-clinical · Barcelona
BeCytes Biotechnologies
BeCytes Biotechnologies
Pre-clinical · Barcelona
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile